Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-977-0 | CAS number: 101-80-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Male rats were dosed orally by gavage or were exposed dermally for six hours to 1 mg [phenyl-l4C(U)]-ODA. Urine and faeces were collected for a period of 48 hours following the oral gavage dose and for 24 hours following the dermal exposure. Organ and tissue distribution of radioactivity was determined for the dermal application group.
Approximately 35.3% and 28.1% of the radioactivity administered to the 0.5 and 200 mg/kg oral dose groups, respectively, was excreted in the urine by 48 hours after dosing; 10.7% of the radioactivity from the 0.5 mg/kg dose was excreted in the urine during the 12-hour post-dosing time interval as compared to 3.6% of the radioactivity from the 200 mg/kg dose. Approximately 28.7% of the radioactivity from the 0.5 mg/kg oral dose and 13.4% of the radioactivity from the 200 mg/kg oral dose was excreted in the faeces by 48 hours. Of the 28.7% excreted by the 0.5 mg/kg dose group, over 19% of the dose was excreted by 24 hours post dose as compared to only about 6% at the 200 mg/kg dose level.
Approximately 7.33% of the dermally applied 1 mg [phenyl-14C(U)]-ODA was absorbed into the systemic circulation during the six-hour application. Urinary excretion represented 3% of the absorbed dose with 2.46% being excreted in the 12- to 24-hour post-application urine sample. Approximately 0.09% of the applied dose was excreted in the faeces by 24 hours which represents approximately 0.9 pig of the total 1000 pig (1 mg) applied to the skin. Approximately 1.35% (0.98 u.g) of the absorbed dose (72.6 pig) was excreted in the faeces by the 24-hour sacrifice. Over 94%, of the absorbed dose remained in the tissues and carcass at the 24-hour sacrifice; of this, approximately 87% remained in the applied skin. Urine collected from the dermal penetration test group contained insufficient radioactivity for meaningful HPLC/radioactivity flow analysis.
Two urinary metabolites found in the 200 mg/kg oral dose group 12-hour urine, definitively identified and confirmed by LC-MS, and which co-eluted against authentic standards were monoacetylated ODA (N-ODA) and diacetylated ODA (N,N'-ODA). The remaining fractions were found to be co-elution mixtures of N-acetyl-ODA, N-acetyl hydroxylated-ODA, N-acetyl dihydroxylated-ODA, N,N'-diacetyl-ODA, and N,N'-diacetyl hyroxylated-ODA. Both N-ODA and N,N'-ODA change little in total abundance after glucoronidase/sulfatase enzyme hydrolysis of urine from the 200 mg/kg group.
The dermal application study show ODA is largely retained at the site of application. This suggests a potential for continued release of ODA or ODA-metabolites from the skin reservoir into the systemic circulation. The oral application study demonstrates the excretion of test substance via metabolisation, although absorption is not specified.
On the basis of this study alone, it is not possible to predict the overall potential for bioaccumulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.